Medications

New drug approved for irritable bowel, chronic constipation

(HealthDay)—Linzess (linaclotide) has been approved by the U.S. Food and Drug Administration to treat forms of chronic constipation that don't respond to traditional treatment, and irritable bowel syndrome accompanied by ...

Oncology & Cancer

Researchers to test 'breakthrough' pediatric leukemia treatment

A promising method of immunotherapy to treat children with relapsed acute lymphocytic leukemia (ALL) is opening at the University of Wisconsin Carbone Cancer Center and American Family Children's Hospital. The trial is open ...

Medications

US watchdog warns on fitness stimulant

The US Food and Drug Administration on Friday questioned the safety of DMAA, a stimulant used in dietary supplements, alleging that marketers were illegally selling the chemical.

HIV & AIDS

US approves new once-a-day pill to treat HIV (Update)

A new pill to treat HIV infection—combining two previously approved drugs plus two new ones—has been approved for adults living with the virus that causes AIDS, US regulators said Monday.

Medications

FDA warns of rare skin reactions to acetaminophen

(HealthDay)—The widely used painkiller acetaminophen, best known as Tylenol, can cause rare but serious skin reactions and a warning about this danger will be added to product labels, the U.S. Food and Drug Administration ...

Ophthalmology

Cutting-edge implant helps patients see clearly

A Sunrise, Fla., surgeon is among the first in the nation to perform a stitch-less implant in the eye to correct both acute myopia and astigmatism, a debilitating pair of conditions that afflict millions of Americans.

Oncology & Cancer

Pazopanib shows better quality-of-life in advanced kidney cancer

Two oral targeted drugs approved for metastatic kidney cancer worked equally well, but one proved superior in tolerability, according to results of a large international clinical trial led by researchers at Dana-Farber Cancer ...

page 17 from 40